Delivery Order SPE2DB20D2014-SPE2DB25FD16A
- Not listed
- The Defense Logistics Agency awarded a $11,793.60 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 17, 2025, and performance will be conducted at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award...
- The Defense Logistics Agency awarded a delivery order valued at $15,748.58 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen...
- The Defense Logistics Agency has awarded a delivery order valued at $1,228.50 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60 count). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by September 29, 2025. The contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $95,172.85 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 26, 2025, with completion targeted for August 27, 2025. This competitive award, issued under firm fixed pricing terms, supports federal medical procurement needs through AmerisourceBergen's established supply chain. The contract specifies performance from the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,259.49 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $4,119.68. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of October 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office operations based in Conshohocken, Pennsylvania, where the company maintains its primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $11,649.50 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 20, 2025, with completion scheduled for August 21, 2025. This non-set-aside contract employs firm fixed pricing and represents a direct fulfillment order under AmerisourceBergen's existing contract vehicle with the DLA. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,965.60 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 19, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical will be supplied from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) with a firm fixed price ceiling value of $7,862.40 and an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999...
- The Defense Logistics Agency awarded a delivery order valued at $14,153.62 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child delivery order under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD16ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $35,762.16 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on September 28, 2025, with completion scheduled for September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The company, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's comprehensive IDC vehicle (SPE2DX) valued at $999,999,999.00 through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency programs and other federal healthcare systems globally. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling medical supply requirements across multiple therapeutic domains, positioning the company as a primary vendor for DLA's pharmaceutical support operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.8k | 9/28/25 |